Cancer Care Ontario | Action Cancer Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

302 Results

Document

IMPACT_Newsletter_Fifth_Edition

Nov 2019

Regimen

IBRU+RITU

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

iBRUtinib (Unfunded),

riTUXimab (Unfunded)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Document

H-FIT_PCC_4160_CCAM_Poster_EN_FINAL

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Postcard_EN_V05

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Poster_EN_PRINT

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Postcard_EN_PRINT

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Postcard_FRCA_PRINT

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Postcard_FRCA_V05

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Poster_FRCA_PRINT

Dec 1969

Document

H-FIT_PCC_4160_CCAM_Poster_FRCA_V04

Dec 1969

Document

IMPACT_Final_Six Edition.pdf

Dec 1969

Statistical Reports

Indice de qualité du système de prévention 2020

Oct 2020

Pages